Risk of specific congenital abnormalities in offspring of women with diabetes

Gunnar Lauge Nielsen, B. Nørgard, E. Puhó, K. J. Rothman, H. T. Sørensen, E. Czeizel

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Aims: To assess the extent to which the increased risk of congenital abnormalities seen in women with pre-gestational insulin-treated diabetes mellitus is unspecific or related to the embryology of specific organs. Methods: Cases with congenital abnormalities were identified in the population-based Hungarian Congenital Abnormality Registry from 1980 to 1996 with two newborn children without congenital abnormality selected from the National Birth Registry as controls. We adjusted for parity, maternal age, and use of antipsychotic drugs. Results: Among cases we found 63/22 843 babies with maternal diabetes compared with 50/38 151 in the control group [adjusted prevalence odds ratio (POR) 2.1; 95% CI 1.5-3.1]. The association was strongest for the following congenital abnormalities: renal agenesis (POR: 14.8; 95% CI, 3.5-62.1), obstructive congenital abnormalities of the urinary tract (POR: 4.3; 95% CI, 1.3-13.9), cardiovascular congenital abnormalities (POR: 3.4; 95% CI, 2.0-5.7), and multiple congenital abnormalities (POR: 5.0; 95% CI, 2.4-10.2). Conclusions: These data indicate that pre-gestational maternal diabetes is associated with strong teratogenic effects on the kidney, urinary tract, and heart, and strongly associated with multiple congenital abnormalities. We found no material association between diabetes and spinal congenital abnormalities and limb deficiencies.

Original languageEnglish
Pages (from-to)693-696
Number of pages4
JournalDiabetic Medicine
Volume22
Issue number6
DOIs
Publication statusPublished - Jun 2005

Fingerprint

Odds Ratio
Multiple Abnormalities
Urinary Tract
Registries
Surrogate Mothers
Cardiovascular Abnormalities
Embryology
Gestational Diabetes
Maternal Age
Parity
Antipsychotic Agents
Diabetes Mellitus
Extremities
Mothers
Parturition
Newborn Infant
Insulin
Kidney
Control Groups
Population

Keywords

  • Maternal diabetes
  • Specific congenital abnormalities

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Risk of specific congenital abnormalities in offspring of women with diabetes. / Nielsen, Gunnar Lauge; Nørgard, B.; Puhó, E.; Rothman, K. J.; Sørensen, H. T.; Czeizel, E.

In: Diabetic Medicine, Vol. 22, No. 6, 06.2005, p. 693-696.

Research output: Contribution to journalArticle

Nielsen, Gunnar Lauge ; Nørgard, B. ; Puhó, E. ; Rothman, K. J. ; Sørensen, H. T. ; Czeizel, E. / Risk of specific congenital abnormalities in offspring of women with diabetes. In: Diabetic Medicine. 2005 ; Vol. 22, No. 6. pp. 693-696.
@article{4145b50f7aa1488ab0f86f8d098253cf,
title = "Risk of specific congenital abnormalities in offspring of women with diabetes",
abstract = "Aims: To assess the extent to which the increased risk of congenital abnormalities seen in women with pre-gestational insulin-treated diabetes mellitus is unspecific or related to the embryology of specific organs. Methods: Cases with congenital abnormalities were identified in the population-based Hungarian Congenital Abnormality Registry from 1980 to 1996 with two newborn children without congenital abnormality selected from the National Birth Registry as controls. We adjusted for parity, maternal age, and use of antipsychotic drugs. Results: Among cases we found 63/22 843 babies with maternal diabetes compared with 50/38 151 in the control group [adjusted prevalence odds ratio (POR) 2.1; 95{\%} CI 1.5-3.1]. The association was strongest for the following congenital abnormalities: renal agenesis (POR: 14.8; 95{\%} CI, 3.5-62.1), obstructive congenital abnormalities of the urinary tract (POR: 4.3; 95{\%} CI, 1.3-13.9), cardiovascular congenital abnormalities (POR: 3.4; 95{\%} CI, 2.0-5.7), and multiple congenital abnormalities (POR: 5.0; 95{\%} CI, 2.4-10.2). Conclusions: These data indicate that pre-gestational maternal diabetes is associated with strong teratogenic effects on the kidney, urinary tract, and heart, and strongly associated with multiple congenital abnormalities. We found no material association between diabetes and spinal congenital abnormalities and limb deficiencies.",
keywords = "Maternal diabetes, Specific congenital abnormalities",
author = "Nielsen, {Gunnar Lauge} and B. N{\o}rgard and E. Puh{\'o} and Rothman, {K. J.} and S{\o}rensen, {H. T.} and E. Czeizel",
year = "2005",
month = "6",
doi = "10.1111/j.1464-5491.2005.01477.x",
language = "English",
volume = "22",
pages = "693--696",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Risk of specific congenital abnormalities in offspring of women with diabetes

AU - Nielsen, Gunnar Lauge

AU - Nørgard, B.

AU - Puhó, E.

AU - Rothman, K. J.

AU - Sørensen, H. T.

AU - Czeizel, E.

PY - 2005/6

Y1 - 2005/6

N2 - Aims: To assess the extent to which the increased risk of congenital abnormalities seen in women with pre-gestational insulin-treated diabetes mellitus is unspecific or related to the embryology of specific organs. Methods: Cases with congenital abnormalities were identified in the population-based Hungarian Congenital Abnormality Registry from 1980 to 1996 with two newborn children without congenital abnormality selected from the National Birth Registry as controls. We adjusted for parity, maternal age, and use of antipsychotic drugs. Results: Among cases we found 63/22 843 babies with maternal diabetes compared with 50/38 151 in the control group [adjusted prevalence odds ratio (POR) 2.1; 95% CI 1.5-3.1]. The association was strongest for the following congenital abnormalities: renal agenesis (POR: 14.8; 95% CI, 3.5-62.1), obstructive congenital abnormalities of the urinary tract (POR: 4.3; 95% CI, 1.3-13.9), cardiovascular congenital abnormalities (POR: 3.4; 95% CI, 2.0-5.7), and multiple congenital abnormalities (POR: 5.0; 95% CI, 2.4-10.2). Conclusions: These data indicate that pre-gestational maternal diabetes is associated with strong teratogenic effects on the kidney, urinary tract, and heart, and strongly associated with multiple congenital abnormalities. We found no material association between diabetes and spinal congenital abnormalities and limb deficiencies.

AB - Aims: To assess the extent to which the increased risk of congenital abnormalities seen in women with pre-gestational insulin-treated diabetes mellitus is unspecific or related to the embryology of specific organs. Methods: Cases with congenital abnormalities were identified in the population-based Hungarian Congenital Abnormality Registry from 1980 to 1996 with two newborn children without congenital abnormality selected from the National Birth Registry as controls. We adjusted for parity, maternal age, and use of antipsychotic drugs. Results: Among cases we found 63/22 843 babies with maternal diabetes compared with 50/38 151 in the control group [adjusted prevalence odds ratio (POR) 2.1; 95% CI 1.5-3.1]. The association was strongest for the following congenital abnormalities: renal agenesis (POR: 14.8; 95% CI, 3.5-62.1), obstructive congenital abnormalities of the urinary tract (POR: 4.3; 95% CI, 1.3-13.9), cardiovascular congenital abnormalities (POR: 3.4; 95% CI, 2.0-5.7), and multiple congenital abnormalities (POR: 5.0; 95% CI, 2.4-10.2). Conclusions: These data indicate that pre-gestational maternal diabetes is associated with strong teratogenic effects on the kidney, urinary tract, and heart, and strongly associated with multiple congenital abnormalities. We found no material association between diabetes and spinal congenital abnormalities and limb deficiencies.

KW - Maternal diabetes

KW - Specific congenital abnormalities

UR - http://www.scopus.com/inward/record.url?scp=20444419839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444419839&partnerID=8YFLogxK

U2 - 10.1111/j.1464-5491.2005.01477.x

DO - 10.1111/j.1464-5491.2005.01477.x

M3 - Article

C2 - 15910618

AN - SCOPUS:20444419839

VL - 22

SP - 693

EP - 696

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 6

ER -